Bhumyamalaki or Kutki: Which Herb to Support the Liver?

Bhumyamalaki and kutki are not distinguished by their assumed effectiveness, but by what research has actually tested on each. Bhumyamalaki (Phyllanthus amarus) raised enormous hope in the 1980s around hepatitis B, before more recent work tempered that signal. Kutki (Picrorhiza kurroa) has a cleaner controlled trial on acute viral hepatitis, but shares with its plant family a paradoxical hepatotoxic risk documented in related species.

Between bhumyamalaki or kutki, the choice depends on the specific context and, above all, on the caution to observe: these are two herbs that touch the liver, an organ where self-medication is never taken lightly.

Bhumyamalaki: the historic hope for hepatitis B

Bhumyamalaki belongs to the Phyllanthus family, a genus of small herbaceous plants widely used in traditional Indian medicine to support the liver and urinary tract. Its name literally means "amla that grows on the ground," referring to its small round fruits arranged beneath the leaves.

It was an early study, published in 1988 in The Lancet by Thyagarajan and colleagues, that launched scientific interest in this herb: it reported viral antigen clearance in some chronic hepatitis B carriers treated with Phyllanthus amarus (see the study on Google Scholar). This finding had considerable impact, but replication attempts by other teams did not all confirm such a clear-cut effect, and more recent systematic reviews on the Phyllanthus genus in hepatitis B conclude that the data remain heterogeneous and insufficient to make it a treatment.

Kutki: the strongest trial on acute hepatitis

Kutki is a Himalayan mountain herb, whose root is used in Ayurveda as a liver and digestive tonic. A clinical trial by Vaidya and colleagues, published in 1996 in the Journal of Postgraduate Medicine, tested kutki root powder in patients with acute viral hepatitis, double-blind against placebo, at a dose of 375 mg three times daily for two weeks (see the study on Google Scholar). The kutki group showed faster normalization of bilirubin and transaminases than the placebo group, with no serious adverse event reported at this supervised dose.

This is a more methodologically solid finding than bhumyamalaki's on this specific ground, but it concerns a defined clinical situation (medically monitored acute hepatitis), not preventive or long-term maintenance use in an otherwise healthy person.

The shared warning sign for "liver-protective" herbs

This is where caution matters for both herbs. Cases of autoimmune-like hepatitis have been reported in people who consumed guduchi (Tinospora cordifolia), another herb traditionally presented as liver-protective, in unsupervised self-medication. This documented precedent on a "cousin" herb underscores a general rule that applies to both bhumyamalaki and kutki: an herb reputed to be good for the liver is not automatically risk-free for the liver, especially at high doses, with a non-standardized artisanal preparation, or on an already fragile liver.

Comparison table: bhumyamalaki vs kutki

	Bhumyamalaki	Kutki
Botanical name	Phyllanthus amarus	Picrorhiza kurroa
Part used	Whole plant	Root (rhizome)
Main traditional use	Liver, viral hepatitis, urinary tract	Liver, digestion, fever
Available clinical data	Historic study (1988) on hepatitis B, unconfirmed since	Double-blind trial on acute viral hepatitis
Strength of evidence	Old and contested signal	Controlled trial, but of limited scope
Main precaution	Self-medication with a known liver condition	Same, plus liver-panel monitoring recommended on longer courses

How to choose based on your situation

1. General digestive comfort, no diagnosed condition: both herbs are traditionally used for this, in a short course at a moderate dose.
2. Known liver condition or history (hepatitis, cirrhosis, fatty liver): neither bhumyamalaki nor kutki should be taken without prior hepatology advice and lab monitoring.
3. Wanting the most methodologically solid signal available: kutki's controlled trial offers a more rigorous methodology than bhumyamalaki's historic signal, without making it a validated treatment.

In either case, neither herb replaces an antiviral treatment or the medical follow-up of a liver condition. These are traditional supportive herbs, not therapeutic alternatives.

Shared precautions

Any liver abnormality (jaundice, dark urine, unusual fatigue, right-sided pain under the ribs) should be evaluated by a doctor before taking either herb.

• Bhumyamalaki: avoid during ongoing treatment for viral hepatitis without medical advice, for lack of sufficient interaction data.
• Kutki: very bitter taste, sometimes poorly tolerated digestively at a high dose; liver-panel monitoring advised on a course of several weeks.
• Pregnancy and breastfeeding: both herbs are best avoided as a precaution, for lack of sufficient safety data.
• Product quality: choose a powder or extract with the exact botanical species stated, with traceability, to limit contamination risk.

For a full overview of the interactions and warning signs to know before any course, see our safety and precautions guide. Detailed risk profiles are also available separately: bhumyamalaki, dangers and precautions and kutki, dangers and precautions.